Tandem Diabetes Care Inc (TNDM)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$18.40

Buy

$19.17

arrow-down$-0.20 (-1.06%)

Prices updated at 02 Apr 2026, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.

Income statement

20242025
940m1,015m
490m546m
-99m-167m
-10.54-16.49
-96m-205m
-70m-177m
Sales, General and administrative390m445m
Interest expenses6m6m
Provision for income taxes4m4m
Operating expenses589m713m
Income before taxes-92m-200m
Net income available to common shareholders-96m-205m
-1.47-3.04
Net interest income11m1m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-1.47-3.04
Free cash flow per share-0.5719-1.0273
Book value/share3.58731.947
Debt equity ratio1.5761692.738951

Balance sheet

20242025
Current assets724m618m
Current liabilities247m243m
Total capital571m465m
Total debt474m444m
Total equity263m155m
Total non current liabilities--
Loans308m310m
Total assets968m881m
Total liabilities--
Cash and cash equivalents69m91m
Common stock66m68m

Cash flow

20242025
Cash at beginning of period59m69m
Cash dividends paid--
5m-108m
Investments (gains) losses-23m73m
69m91m
Net income--
24m-10m
-19m-99m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.